We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

159 hedge funds and large institutions have $1.55B invested in Mirum Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 31 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 31

88% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 17

62% more capital invested

Capital invested by funds: $956M → $1.55B (+$590M)

30.63% more ownership

Funds ownership: 97.14% → 127.77% (+31%)

9% more funds holding

Funds holding: 146 → 159 (+13)

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

13% less call options, than puts

Call options by funds: $2M | Put options by funds: $2.29M

Holders
159
Holders Change
+13
Holders Change %
+8.9%
% of All Funds
2.52%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
32
Increased
68
Reduced
31
Closed
17
Calls
$2M
Puts
$2.29M
Net Calls
-$291K
Net Calls Change
+$555K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$120M
2
FLSM
Frazier Life Sciences Management
California
+$57.8M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$45.4M
4
APM
Avidity Partners Management
Texas
+$31.3M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$18.2M

Top Sellers

Rank Fund Capital Flow
1
RVM
RiverVest Venture Management
Missouri
-$41.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$15.5M
3
PM
Prosight Management
Texas
-$8.8M
4
WA
Wasatch Advisors
Utah
-$5.96M
5
NHAS
Novo Holdings A/S
Denmark
-$5.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJA
51
Raymond James & Associates
Florida
$3.36M +$1.06M +38,619 +57%
SCM
52
Soleus Capital Management
Connecticut
$3.25M -$2M -73,000 -41%
AAP
53
Ardsley Advisory Partners
Connecticut
$3.16M +$2.74M +100,000 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
54
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$3.16M +$2.74M +100,000 New
JP Morgan Chase
55
JP Morgan Chase
New York
$3.15M +$1.68M +61,311 +159%
Squarepoint
56
Squarepoint
New York
$3.15M +$1.71M +62,398 +167%
CSS
57
Cubist Systematic Strategies
Connecticut
$3.1M +$2.58M +94,104 +2,347%
JF
58
Jump Financial
Illinois
$2.76M +$2.05M +75,024 +607%
SAM
59
Simplify Asset Management
Nevada
$2.21M – – –
Renaissance Technologies
60
Renaissance Technologies
New York
$2.17M +$1.56M +57,100 +492%
IBT
61
International Biotechnology Trust
United Kingdom
$2.13M – – –
Jane Street
62
Jane Street
New York
$2.07M -$4.98M -182,032 -73%
PHP
63
Parkman Healthcare Partners
Connecticut
$2.06M +$72.3K +2,640 +4%
PAI
64
Palo Alto Investors
California
$2.04M – – –
UOC
65
UBS O'Connor
Illinois
$1.93M +$1.01M +37,000 +154%
Citigroup
66
Citigroup
New York
$1.86M +$491K +17,917 +44%
KOCAA
67
Knights of Columbus Asset Advisors
Connecticut
$1.83M +$22.4K +817 +1%
Swiss National Bank
68
Swiss National Bank
Switzerland
$1.72M +$19.2K +700 +1%
RHJA
69
Rice Hall James & Associates
California
$1.69M -$29.4K -1,075 -2%
RJFSA
70
Raymond James Financial Services Advisors
Florida
$1.58M +$325K +11,862 +31%
Los Angeles Capital Management
71
Los Angeles Capital Management
California
$1.34M +$13.5K +494 +1%
SAM
72
Secure Asset Management
Michigan
$1.25M +$113K +4,144 +12%
AllianceBernstein
73
AllianceBernstein
Tennessee
$1.23M +$83.1K +3,034 +8%
UBS AM
74
UBS AM
Illinois
$1.23M +$437K +15,961 +70%
VFA
75
Values First Advisors
Tennessee
$1.2M +$1.04M +37,919 New
1 2
3
4 5

MIRM Hedge Fund Activity: Q3 2023 in Review

159 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q3 2023, worth a combined $1.55B — up 62% from $956M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new MIRM positions and 17 closed out — a net gain of 15 holders — while 68 added to existing stakes and 31 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $120M. The largest seller was RiverVest Venture Management, exiting entirely with an estimated $41.9M sold.

  • 159 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q3 2023, up from 146 in Q2 2023.
  • Funds reported $1.55B of Mirum Pharmaceuticals stock for Q3 2023, up 62% quarter-over-quarter.
  • 32 funds opened new Mirum Pharmaceuticals positions in Q3 2023 and 17 closed out, a net change of +15 holders.
  • The largest Mirum Pharmaceuticals buyer in Q3 2023 was BVF Inc, an estimated $120M added.
  • The largest Mirum Pharmaceuticals seller in Q3 2023 was RiverVest Venture Management, an estimated $41.9M sold.

Based on aggregated 13F filings for Q3 2023.